Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.695 USD | +3.59% |
|
-12.95% | -50.59% |
Jun. 11 | Nestle's Health Unit to Take Full Control of Microbiota-Based Therapeutic | CI |
Jun. 07 | Canaccord Genuity Adjusts Price Target on Seres Therapeutics to $10 From $15, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.07% | 102M | |
+16.14% | 122B | |
+19.53% | 113B | |
+3.09% | 22.66B | |
-17.15% | 21.34B | |
-39.57% | 16.92B | |
-14.01% | 16.68B | |
-16.43% | 16.61B | |
+2.83% | 13.62B | |
+21.45% | 11.04B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Transcript : Seres Therapeutics, Inc., Q4 2022 Earnings Call, Mar 07, 2023